Our Blog

Male Factor in Infertility - Creative Love Egg donor Agency

The Male Factor in Infertility

I think many couples overlook the male factor when it comes to their infertility challenges. Infertility statistics  state that 40% of infertility problems are with the female, 40% with the male  and 20% as a couple combined. The world of infertility doesn’t offer men as many different test options as it does women.  The standard infertility tests on the market as of now for men is 18% vs 96% for women.

AndroJek and UniLab a leading infertility lab in South Florida have teamed together to offer a new test panel for male factor issues. The Male Reproductive Health Panel, MRH consists of a group of diagnostic tests used to assess sperm for both functional capability, and genomic integrity to complete the post-fertilization process resulting in an embryo.

What is the Male Reproductive Health℠ Panel (MRH)?

Did you know…?

60% of infertility is male-factor related
47% of males tested with the MRH Panel were found to have male factor issues

This is a huge leap forward in diagnostic accuracy.

The goal of the Male Reproductive Health℠ Panel is to identify the best treatment path for up to 47% of infertile males. The MRH Panel is a quantum leap forward in the ability to screen and diagnose sperm. MRH is world patented and combines the use of proprietary and non-proprietary technologies to interpret the optimal treatment path. With the MRH Panel, you are looking at sperm function, oxidative (ROS) damage, and structural issues. This provides the most holistic look at sperm health and use in a clinical setting!

The Male Reproductive Health℠ Panel consists of a group of high-complexity diagnostic tests used to assess sperm DNA for structural stability and functional capability in the post-fertilization process. The MRH panel provides patients with all of the tests you have read about on our site including, the Sperm DNA Decondensation (SDD™), Sperm DNA Accelerated DNA Decondensation (SDAD™), and Sperm Chromatin Fragmentation Assay (SCFA™).

Why should I have the Male Reproductive Health panel?

Benefit #1: The MRH panel provides you with 3 unique diagnostic tests. These tests will address the male diagnostic shortfall to better identify a portion of the 60% male infertility component currently going undetected. You can have all of these tests performed in the same visit to your doctor and get answers that will help you determine the proper treatment path which will ultimately save you time, money and emotional stress.

Benefit #2: The MRH panel is the only solution to optimize treatment for the 47% of infertile males and will help in identifying the couples’ unexplained infertility. SDD test accounts for 25%, SDAD for 10%, and SCFA accounts for 12%.

Benefit #3: The MRH panel provides patient-specific information for a greater degree of personalized medicine and treatment by focusing on DNA Integrity and Sperm Function, compared to standard, superficial semen analysis.

What can the Male Reproductive Health panel do for my patients and my practice?


The MRH panel has many beneficial factors not only for patients but for your doctors/physicians as well. Some of them are the following:
  • Increased success rates by eliminating wasted time on treatments with little chance of success.
  • Improved counseling on upfront ART options reduces patient dropout, enhancing the chances of bringing home a baby sooner
  • Minimize trial and error with other ART methods leading to an accumulation of failed ART attempts and patient frustration.
  • Enhanced reputation among the infertility patient community.
  • Evidenced based medicine to provide couples with the best treatment option.
The Male Reproductive Health panel vs. Semen Analysis

Semen Analysis is very traditional and basic testing. As a superficial measure, the results only provide information regarding your sperm concentration (count), morphology (size and shape) and motility (movement), not about what makes your sperm function and work during fertilization. With a normal semen analysis, the non ART treatment options would be:

  • Blind Varicocoelectomy
  • Blind Anti-Oxidant Therapy

The MRH panel provides a superior profile that is personalized and objective. It will give you targeted ART treatment courses as well as non-ART options such as:

  • Targeted Varicocoelectomy
  • Targeted Anti-Oxidant Therapy
  • Remove and eliminate toxicant exposure